Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;38:1-11.
doi: 10.1016/j.jnutbio.2016.03.002. Epub 2016 Mar 24.

The Pleiotropic Effects of omega-3 Docosahexaenoic Acid on the Hallmarks of Alzheimer's Disease

Affiliations
Review

The Pleiotropic Effects of omega-3 Docosahexaenoic Acid on the Hallmarks of Alzheimer's Disease

Mounir Belkouch et al. J Nutr Biochem. .

Abstract

Among omega-3 polyunsaturated fatty acids (PUFAs), docosahexaenoic acid (DHA, 22:6n-3) is important for adequate brain development and cognition. DHA is highly concentrated in the brain and plays an essential role in brain functioning. DHA, one of the major constituents in fish fats, readily crosses the blood-brain barrier from blood to the brain. Its critical role was further supported by its reduced levels in the brain of Alzheimer's disease (AD) patients. This agrees with a potential role of DHA in memory, learning and cognitive processes. Since there is yet no cure for dementia such as AD, there is growing interest in the role of DHA-supplemented diet in the prevention of AD pathogenesis. Accordingly, animal, epidemiological, preclinical and clinical studies indicated that DHA has neuroprotective effects in a number of neurodegenerative conditions including AD. The beneficial effects of this key omega-3 fatty acid supplementation may depend on the stage of disease progression, other dietary mediators and the apolipoprotein ApoE genotype. Herein, our review investigates, from animal and cell culture studies, the molecular mechanisms involved in the neuroprotective potential of DHA with emphasis on AD.

Keywords: Alzheimer's disease; ApoE e4; DHA; Neurodegeneration; Neuroprotection.

Similar articles

See all similar articles

Cited by 20 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback